ArticleCancers2024

Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Jonathan N Priantti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.